IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.
Also called NCT02711098
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 116 participants
- Registry
-
NCT02711098
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT02711098. Randomized; single masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-01-14 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IL Ancillary Study of the Therapeutic Hypothermia After Nonshockable Cardiac Arrest Trial.
- Acronym
- IL-HYPERION
- Condition
- Cardiac Arrest
- Intervention (Biological)
- Inflammatory biomarkers dosage "Hypothermia Arm"
- Intervention (Biological)
- Inflammatory biomarkers dosage "Normothermia Arm"
- Lead sponsor
- Centre Hospitalier Departemental Vendee
Record details
- Record id
cardio:ct-nct02711098- Content hash
7f6aee275098ca7da00d815144a9ddfb9eca42aca04208d7389739cf9fb99828